SELLAS Life Sciences Group, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
SELLAS Life Sciences Group, Inc. (SLS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 15.69 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-11
- SELLAS Life Sciences Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 35.21M shares, a 57.49% decline year-over-year.
- SELLAS Life Sciences Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 82.82M shares, a 85.31% increase year-over-year.
- SELLAS Life Sciences Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 44.70M shares, a 208.97% increase year-over-year.
- SELLAS Life Sciences Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 14.47M shares, a 694.40% increase year-over-year.
- SELLAS Life Sciences Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 62.03M shares, a 6.46% increase from fiscal 2024.
- SELLAS Life Sciences Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 58.26M shares, a 227.34% increase from fiscal 2023.
- SELLAS Life Sciences Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 17.80M shares, a 176.55% increase from fiscal 2022.
- SELLAS Life Sciences Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 6.44M shares, a 413.65% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 15.69M shares 10-Q · filed 2026-08-11 | |||||||
| 2026-03-31 | 35.21M shares 10-Q · filed 2026-05-12 | |||||||
| 2025-12-31 | 62.03M shares 10-K · filed 2026-03-19 | |||||||
| 2025-09-30 | 68.06M shares 10-Q · filed 2025-11-12 | |||||||
| 2025-06-30 | 73.35M shares 10-Q · filed 2026-08-11 | |||||||
| 2025-03-31 | 82.82M shares 10-Q · filed 2026-05-12 | |||||||
| 2024-12-31 | 58.26M shares 10-K · filed 2026-03-19 | |||||||
| 2024-09-30 | 68.03M shares 10-Q · filed 2025-11-12 | |||||||
| 2024-06-30 | 42.91M shares 10-Q · filed 2025-08-12 | |||||||
| 2024-03-31 | 44.70M shares 10-Q · filed 2025-05-13 | |||||||
| 2023-12-31 | 17.80M shares 10-K · filed 2025-03-20 | |||||||
| 2023-09-30 | 14.30M shares 10-Q · filed 2024-11-13 | |||||||
| 2023-06-30 | 14.46M shares 10-Q · filed 2024-08-13 | |||||||
| 2023-03-31 | 14.47M shares 10-Q · filed 2024-05-14 | |||||||
| 2022-12-31 | 6.44M shares 10-K · filed 2024-03-28 | |||||||
| 2022-09-30 | 6.52M shares 10-Q · filed 2023-11-09 | |||||||
| 2022-06-30 | 6.46M shares 10-Q · filed 2023-08-10 | |||||||
| 2022-03-31 | 1.82M shares 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | 1.25M shares 10-K · filed 2023-03-16 | |||||||
| 2021-09-30 | 1.29M shares 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | 1.29M shares 10-Q · filed 2022-08-11 | |||||||
| 2021-03-31 | 1.26M shares 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | 1.77M shares 10-K · filed 2022-03-31 | |||||||
| 2020-09-30 | 4.24M shares 10-Q · filed 2021-11-12 | |||||||
| 2020-06-30 | 1.50M shares 10-Q · filed 2021-08-12 | |||||||
| 2020-03-31 | 1.48M shares 10-Q · filed 2021-05-13 | |||||||
| 2019-12-31 | 324.00K shares 10-K · filed 2021-03-23 | |||||||
| 2019-09-30 | 325.00K shares 10-Q · filed 2020-11-13 | |||||||
| 2019-06-30 | 2.88M shares 10-Q · filed 2020-08-13 | |||||||
| 2019-03-31 | 381.00K shares 10-Q · filed 2020-05-14 | |||||||
| 2018-12-31 | 364.00K shares 10-K · filed 2020-03-13 | 18.11M shares 10-K · filed 2019-03-22 | ||||||
| 2017-12-31 | 986.00K shares 10-K · filed 2019-03-22 | 986.00 shares 10-K · filed 2018-04-13 | ||||||
| 2017-09-30 | 20.00M shares 10-Q · filed 2017-11-09 | |||||||
| 2017-06-30 | 20.06M shares 10-Q · filed 2017-08-14 | 20.06M shares 10-Q · filed 2017-08-14 | ||||||
| 2017-03-31 | 20.13M shares 10-Q · filed 2017-05-10 | |||||||
| 2016-12-31 | 122.00 shares 10-K · filed 2018-04-13 | 3.13M shares 10-K · filed 2017-03-15 | ||||||
| 2016-09-30 | 3.09M shares 10-Q · filed 2017-11-09 | 61.76M shares 10-Q · filed 2016-11-09 | ||||||
| 2016-06-30 | 1.40M shares 10-Q · filed 2017-08-14 | 27.96M shares 10-Q · filed 2016-08-09 | 2.39M shares 10-Q · filed 2017-08-14 | 47.73M shares 10-Q · filed 2016-08-09 | ||||
| 2016-03-31 | 2.39M shares 10-Q · filed 2017-05-10 | 47.78M shares 10-Q · filed 2016-05-10 | ||||||
| 2015-12-31 | 1.78M shares 10-K · filed 2017-03-15 | 35.57M shares 10-K · filed 2016-03-10 | ||||||
| 2015-09-30 | 33.50M shares 10-Q · filed 2016-11-09 | |||||||
| 2015-06-30 | 33.72M shares 10-Q · filed 2016-08-09 | 33.72M shares 10-Q · filed 2016-08-09 | ||||||
| 2015-03-31 | 33.23M shares 10-Q · filed 2016-05-10 | |||||||
| 2014-12-31 | 17.13M shares 10-K/A · filed 2016-04-15 | |||||||
| 2014-09-30 | 17.53M shares 10-Q · filed 2014-11-05 | 17.53M shares 10-Q · filed 2015-11-09 | ||||||
| 2014-06-30 | 19.63M shares 10-Q · filed 2014-08-11 | 19.41M shares 10-Q · filed 2015-08-06 | ||||||
| 2014-03-31 | 19.41M shares 10-Q · filed 2015-05-07 | |||||||
| 2013-12-31 | 28.01M shares 8-K · filed 2015-12-04 | |||||||
| 2013-09-30 | 28.83M shares 10-Q · filed 2014-11-05 | |||||||
| 2013-06-30 | 22.38M shares 10-Q · filed 2014-08-11 | 22.38M shares 10-Q · filed 2013-08-09 | ||||||
| 2013-03-31 | 22.48M shares 10-Q · filed 2014-05-06 | 22.48M shares 10-Q · filed 2013-05-09 | ||||||
| 2012-12-31 | 20.89M shares 10-K · filed 2014-03-17 | 20.89M shares 10-K · filed 2013-03-12 | ||||||
| 2012-09-30 | 13.29M shares 10-Q/A · filed 2013-11-07 | |||||||
| 2012-06-30 | 11.73M shares 10-Q · filed 2013-08-09 | 25.81M shares 10-Q · filed 2013-08-09 | ||||||
| 2012-03-31 | 20.55M shares 10-Q · filed 2013-05-09 | |||||||
| 2011-12-31 | 20.28M shares 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |